Clinical Trials

New Search
Title   Targeted Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine Plus Nab-Paclitaxel Following Induction With Sequential IV Gemcitabine Plus Nab-Paclitaxel and Radiotherapy for Locally Advanced Pancreatic Cancer (TIGeR-PaC)
Disease/Condition   Pancreatic Cancer,Surgery,Endocrinology,Neoplasms
Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Peter Muscarella, MD
Contact Name   Alyssa Asaro
Contact Email   aasaro@montefiore.org
IRB/Protocol Number   17-06-310-01
Status   Active/Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No
Sub-Specialty   Pancreatic Cancer